Most common sources are thrombus or vegetation in the heart or aorta, or paradoxically from a venous thrombus through a right-to-left intracardiac shunt.
Absent pulse, pallor, and decreased temperature of limb distal to the occlusion. Diagnosis confirmed by CT, MR, or conventional angiography.
TREATMENT | ||
Arterial EmbolismIV heparin is administered to prevent propagation of clot. For acute severe ischemia, immediate endovascular or surgical embolectomy is indicated. Thrombolytic therapy (e.g., tissue plasminogen activator, reteplase, or tenecteplase) may be effective for recent (<2 weeks) thrombus within atherosclerotic vessel or arterial bypass graft. |
A subset of acute arterial occlusion due to embolization of fibrin, platelets, and cholesterol debris from more proximal atheromas or aneurysm; typically occurs after intraarterial instrumentation. Depending on location, may lead to stroke, renal insufficiency, or pain and tenderness in embolized tissue. Atheroembolism to lower extremities results in blue toe syndrome, which can progress to necrosis and gangrene. Treatment is supportive; for recurrent episodes, surgical intervention in the proximal atherosclerotic vessel or aneurysm may be required.
Thromboangiitis Obliterans (Buerger's Disease)
Typically occurs in men age <40 who are heavy smokers and involves both upper and lower extremities; non-atheromatous inflammatory reaction develops in veins and small arteries, leading to superficial thrombophlebitis and arterial obstruction with ulceration or gangrene of digits. Imaging with CT, MR, or conventional angiography shows smooth tapering lesions in distal vessels, often without proximal atherosclerotic disease. Abstinence from tobacco is essential.
Manifest by Raynaud's phenomenon in which cold exposure results in triphasic color response: blanching of the fingers, followed by cyanosis, then rubor. Most often a benign disorder. However, suspect an underlying disease (Table 128-1 Classification of Raynaud's Phenomenon) if tissue necrosis occurs, if disease is unilateral, or if it develops after age 50.
TREATMENT | ||
Vasospastic DisordersKeep extremities warm. Tobacco use is contraindicated. Dihydropyridine calcium channel blockers (e.g., nifedipine XL 30-90 mg PO qd) or α1-adrenergic antagonists (e.g., prazosin 1-5 mg tid) may be effective. Phosphodiesterase type 5 inhibitors (e.g., sildenafil, tadalafil, vardenafil) may improve symptoms in secondary Raynaud's phenomenon. |